New combinations and targets in advanced prostate cancer
Biotech Strategy Blog,
In yesterday’s post on novel targets in advanced prostate cancer, we looked at a potential new concept that is emerging…
Steroid Sidestep: Evading Androgen Ablation by Abiraterone
Overview of attention for article published in Clinical Cancer Research, March 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (80th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (60th percentile)
Readers on
- mendeley
- 17 Mendeley